J Physiol Society Membership
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Physiol Volume 586, Number 5, 1307-1319, March 1, 2008 DOI: 10.1113/jphysiol.2007.143818
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
586/5/1307    most recent
jphysiol.2007.143818v1
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kang, G.
Right arrow Articles by Holz, G. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kang, G.
Right arrow Articles by Holz, G. G.
Related Collections
Right arrow Cellular

CELLULAR

Role of the cAMP sensor Epac as a determinant of KATP channel ATP sensitivity in human pancreatic β-cells and rat INS-1 cells

Guoxin Kang1, Colin A. Leech1, Oleg G. Chepurny1, William A. Coetzee1,2,3 and George G. Holz1,3

1 Departments of Physiology and Neuroscience
2 Pediatrics
3 Pharmacology, New York University School of Medicine, New York, NY, USA

Protein kinase A (PKA)-independent actions of adenosine 3',5'-cyclic monophosphate (cAMP) are mediated by Epac, a cAMP sensor expressed in pancreatic β-cells. Evidence that Epac might mediate the cAMP-dependent inhibition of β-cell ATP-sensitive K+ channels (KATP) was provided by one prior study of human β-cells and a rat insulin-secreting cell line (INS-1 cells) in which it was demonstrated that an Epac-selective cAMP analogue (ESCA) inhibited a sulphonylurea-sensitive K+ current measured under conditions of whole-cell recording. Using excised patches of plasma membrane derived from human β-cells and rat INS-1 cells, we now report that 2'-O-Me-cAMP, an ESCA that activates Epac but not PKA, sensitizes single KATP channels to the inhibitory effect of ATP, thereby reducing channel activity. In the presence of 2'-O-Me-cAMP (50 µM), the dose–response relationship describing ATP-dependent inhibition of KATP channel activity (NPo) is left-shifted such that the concentration of ATP producing 50% inhibition (IC50) is reduced from 22 µM to 1 µM for human β-cells, and from 14 µM to 4 µM for rat INS-1 cells. Conversely, when patches are exposed to a fixed concentration of ATP (10 µM), the administration of 2'-O-Me-cAMP inhibits channel activity in a dose-dependent and reversible manner (IC50 12 µM for both cell types). A cyclic nucleotide phosphodiesterase-resistant ESCA (Sp-8-pCPT-2'-O-Me-cAMPS) also inhibits KATP channel activity, thereby demonstrating that the inhibitory actions of ESCAs reported here are unlikely to arise as a consequence of their hydrolysis to bioactive derivatives of adenosine. On the basis of such findings it is concluded that there exists in human β-cells and rat INS-1 cells a novel form of ion channel modulation in which the ATP sensitivity of KATP channels is regulated by Epac.

(Received 24 August 2007; accepted after revision 10 January 2008; first published online 17 January 2008)
Corresponding author G. G. Holz: Medical Sciences Building Room 442, 550 First Avenue, New York, NY 10016, USA. Email: holzg01{at}popmail.med.nyu.edu




This article has been cited by other articles:


Home page
JGPHome page
H. Liu, J. A. Enyeart, and J. J. Enyeart
ACTH Inhibits bTREK-1 K+ Channels through Multiple cAMP-dependent Signaling Pathways
J. Gen. Physiol., August 1, 2008; 132(2): 279 - 294.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 The Physiological Society.